Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus
Intrapartale Glukosemetriken und unerwünschte neonatale Outcomes bei Personen mit Gestationsdiabetes mellitus
Pregnancy · 2026-05 · 2 (3)
DOI: 10.1002/pmf2.70308 ↗Auf einen Blick
Bei 59 Gebärenden mit GDM war ein ungünstiges neonatales Outcome mit weniger Zeit im Zielbereich und mehr Zeit über dem Zielbereich während der Geburt verbunden.
Fragestellung
Unterscheiden sich CGM-Metriken unter der Geburt bei GDM zwischen Schwangerschaften mit und ohne zusammengesetztes unerwünschtes neonatales Outcome?
Methode
Sekundäranalyse einer Studie mit GDM-Teilnehmer:innen; Vergleich von CGM-Metriken unter der Geburt zwischen Personen mit und ohne zusammengesetztes neonatales Outcome.
Ergebnisse
59 von 111 Teilnehmer:innen gingen in die Analyse ein. Zielbereich 70–120 mg/dL: 62,7 % vs. 80,7 % (p = 0,012). Time-above-range ≥ 120 mg/dL: 26,7 % vs. 10,6 % (p = 0,007). Mittlere Glukose: 103,9 vs. 94,6 (p = 0,059).
Einschränkungen
52 von 111 Patient:innen wurden ausgeschlossen; 23 wegen fehlender intrapartaler Daten und 29 ohne Geburtsversuch vor Kaiserschnitt.
Schlussfolgerung der Autor:innen
Bei intrapartalen GDM-Teilnehmer:innen war ein zusammengesetztes unerwünschtes neonatales Outcome mit weniger TIR, mehr TAR und höherer mittlerer Glukose unter der Geburt verbunden.
Kernaussagen
- TIR 70–120 mg/dL: 62,7 % vs. 80,7 %
- TAR ≥ 120 mg/dL: 26,7 % vs. 10,6 %
- Mittlere Glukose: 103,9 vs. 94,6; p = 0,059
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy, online erschienen am 15.05.2026. Verfasst von Alexandra C Gallagher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Obstetrics Stanford University Stanford California USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Hyperglycemia is a recognized risk factor for adverse neonatal outcomes. However, the impact of achieving glucose goals during labor on the risk of such outcomes remains poorly understood for individuals with gestational diabetes mellitus (GDM). We sought to compare continuous glucose monitoring (CGM) metrics between laboring GDM pregnancies complicated by adverse neonatal outcomes to those without complications.
Methods
Secondary analysis of pregnant people with GDM randomized to using CGM versus capillary blood glucose (CBG) for management of GDM. Among all participants wearing a CGM during labor, we compared pregnancies that were complicated by a significant neonatal outcome as defined by a composite including one or more of the following: hypoglycemia, hyperbilirubinemia, respiratory distress syndrome, or neonatal intensive care unit admission to those without this composite adverse outcome. Continuous variables were compared with two‐sample t ‐tests, and categorical variables were tested with Fisher's Exact tests. We correlated antepartum to intrapartum glucose management by measuring mean glucose and glucose percent time‐in‐range (TIR; primary intrapartum range 70–120 mg/dL, with candidate ranges 70–110 and 70–140 mg/dL), stratified by composite adverse neonatal outcome.
Results
Of the 111 in the primary trial, 59 were included in this secondary analysis. A total of 52 of 111 patients in the primary trial were excluded, as 23 were missing intrapartum data and 29 had no trial of labor prior to cesarean delivery. The cohort with the composite adverse neonatal outcome spent significantly less intrapartum TIR between 70 and 120 mg/dL (62.7% vs. 80.7%, p = 0.012) and more time‐above‐range (TAR) ≥ 120 mg/dL (26.7% vs. 10.6%, p = 0.007) compared to those with no composite adverse neonatal outcome. The mean glucose for those with adverse neonatal outcomes was non‐significantly higher than those without (103.9 vs. 94.6, p = 0.059). There was a weak‐to‐moderate positive correlation between antenatal and intrapartum glucose management.
Conclusion
Intrapartum participants with GDM and a composite adverse neonatal outcome spent less TIR, more TAR, with a higher mean glucose in labor than those without a composite adverse outcome. A weak‐to‐moderate positive correlation between antenatal and intrapartum glucose management was observed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Obstetrics Stanford University Stanford California USA.
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine Oregon Health & Science University Portland Oregon USA.
ORCID-Profile: Alexandra C Gallagher, Alyssa R Hersh, Amy M Valent
Zitieren
APA
Gallagher, A. C., Hersh, A. R., Ward, L., & Valent, A. M. (2026). Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus. Pregnancy, 2(3). https://doi.org/10.1002/pmf2.70308
Vancouver
Gallagher AC, Hersh AR, Ward L, Valent AM. Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus. Pregnancy. 2026;2(3). doi:10.1002/pmf2.70308
BibTeX
@article{Gallagher2026,
author = {Gallagher, Alexandra C and Hersh, Alyssa R and Ward, Lucy and Valent, Amy M},
title = {Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus},
journal = {Pregnancy},
year = {2026},
volume = {2},
number = {3},
doi = {10.1002/pmf2.70308}
}
EUVIMED